2-Hydroxypropyl-β-cyclodextrin Chemical Properties

Melting point:

278 °C (dec.)

Boiling point:

400℃

Density 

1.05 at 20.3℃

refractive index 

125 ° (C=1, H2O)

storage temp. 

room temp

solubility 

H₂O: 45 % (w/v)

form 

solution (clear, colorless)

color 

White to slightly yellow

optical activity

[α]26/D +139°, c = 1 in H2O

Water Solubility 

Soluble in water.

InChIKey

ODLHGICHYURWBS-FOSILIAISA-N

LogP

-4 at 20℃

Surface tension

63.6-65mN/m at 1g/L and 22℃

EPA Substance Registry System

.beta.-Cyclodextrin, 2-hydroxypropyl ethers (128446-35-5)

Safety Information

Safety Statements 

24/25

WGK Germany 

3

RTECS 

GU2293332

TSCA 

Yes

HS Code 

29400090

Toxicity

mouse,LD,intravenous,> 5gm/kg (5000mg/kg),Journal of Pharmaceutical Sciences. Vol. 84, Pg. 1223, 1995.

MSDS

• Language:English Provider:SigmaAldrich

2-Hydroxypropyl-β-cyclodextrin Usage And Synthesis

Chemical Properties

White to slightly yellow powder

Chemical Properties

Hydroxypropyl betadex occurs as a white or almost white, amorphous or crystalline powder.

Uses

enteric coating, sustained release formulations, buccal and transdermal drug delivery

Uses

2-Hydroxypropyl-β-cyclodextrin can be used as selective estrogen receptor modulator for the prevention of osteoporosis

Uses

2-Hydroxypropyl-β-cyclodextrin (HBC) is a widely used modified cyclodextrin, the lipophilic cavity formed by 7 glucose units. Drug solubility in water is greatly enhanced by complexing with 2-Hydroxypropyl-β-cyclodextrin.

Production Methods

Hydroxypropyl betadex is prepared by the treatment of an alkaline solution of b-cyclodextrin with propylene oxide. The substitution pattern can be influenced by varying the pH. Formation of O-6 and O-2 substituted products is favored by high and low alkali concentration, respectively. The mixture of products produced may be refined by preparative chromatography.

General Description

(2-Hydroxypropyl)-β-cyclodextrin, a hydroxyalkyl derivative, finds application as a formulation vehicle that is used to enhance the solubility of the drugs in aqueous solutions for the successful delivery of medical agents to biological systems. It is generally employed as a substitute for α-, β- and γ-cyclodextrins.

Pharmaceutical Applications

Hydroxypropyl betadex has been widely investigated in pharmaceutics and has principally been used as a solubilizer for hydrophobic molecules in oral liquids,oral solids, parenterals, pressurized metered dose inhalers, dry powder inhalers, and topical formulations. It has also been shown to act as a stabilizer during processing and storage of formulations.
Hydroxypropyl betadex inclusion complexes have been reported to show mechanical properties distinct from the pure materials. The reported advantage of hydroxypropyl betadex over unsubstituted b-cyclodextrin is its greater water solubility.

Biological Activity

Cell treatment with HPβCD results in the activation of the transcription factor EB, a master regulator of lysosomal function and autophagy, and in the enhancement of the cellular autophagic clearance capacity. HPβCD administration promotes transcription factor EB-mediated clearance of proteolipid aggregates that accumulate due to inefficient activity of the lysosome-autophagy system in cells derived from a patient with a lysosomal storage disorder. Interestingly, HPβCD-mediated activation of autophagy was found not to be associated with activation of apoptotic pathways[2].

Side effects

2-Hydroxypropyl-β-cyclodextrin (HP-beta-CD) has been shown to be well tolerated in humans, with the main adverse event being diarrhoea and there have been no adverse events on kidney function, documented to date[1].

Safety

The pharmaceutical toxicology of hydroxypropyl betadex has been reviewed, and in general, the material was found to be of low toxicity. It has been suggested that hydroxypropyl betadex may have a synergistic toxic effect with, for example, carcinogens, by increasing their solubility and thus bioavailability.

storage

Store in well-closed containers.

Regulatory Status

Included in oral and parenteral medicinal products. Included in an injectable preparation licensed in the UK for intramuscular or intravenous administration.

References

[1] Sarah Gould, Robert C. Scott. “2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review.” Food and Chemical Toxicology 43 10 (2005): Pages 1451-1459.
[2] Wensi Song. “2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy.” The Journal of Biological Chemistry (2014): 10211–22.

2-Hydroxypropyl-β-cyclodextrin(128446-35-5)Related Product Information

• HYDROXYPROPYL-BETA-CYCLODEXTRIN
• Hydroxypropyl cellulose
• Hydroxypropyl methyl cellulose
• (2-Hydroxypropyl)-γ-cyclodextrin
• 2-hydroxypropyl-α-cyclodextrin
• Hydroxypropyl methylcellulose phthalate
• β-Cyclodextrin
• D-(+)-DIGITOXOSE
• 6-Deoxy-L-glucose
• L-SORBITOL
• METHYL-Β-D-ARABINO- PYRANOSIDE
• 2-Hydroxypropyl-β-cyclodextrin
• D-Arabinpyranose
• Dextrin
• beta-Cyclodextrin hydrate
• SUCCINYL-(2-HYDROXYPROPYL)-BETA-CYCLODEXTRIN
• .alpha.-D-Arabinopyranoside, methyl
• D-TALITOL